It is possible that these genetic variations are population-specific events (i.e., genetic variants whose allele frequencies are significantly higher in one population compared to others) that could contribute in part to the differences in the prevalence of HER2-positive breast tumors among population groups (21). The gene discussed is ERBB2; the disease is breast neoplasm.